Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI
Yi Xiang1, Jianqiao Peng2, Qiong Liu2
1Department of Geriatrics, People's Hospital of Hunan Province, Changsha, Hunan 410006, P.R. China.
Insights
Investigating CD69 and EGR1 levels in coronary heart disease (CHD) patients undergoing percutaneous coronary intervention (PCI) revealed their association with no-reflow events. Elevated CD69 and decreased EGR1 indicate potential no-reflow, aiding timely intervention.
Area of Science:
- Cardiology
- Biomarkers
- Interventional Cardiology
Background:
- Percutaneous coronary intervention (PCI) is a common procedure for coronary heart disease (CHD).
- No-reflow phenomenon after PCI can lead to adverse cardiac events and poorer prognosis.
- Identifying reliable biomarkers for predicting no-reflow is crucial for patient management.
Purpose of the Study:
- To investigate the association between CD69 and EGR1 levels and the occurrence of no-reflow in CHD patients post-PCI.
- To determine if CD69 and EGR1 can serve as predictive markers for no-reflow after PCI.
Main Methods:
- A cohort of 156 CHD patients undergoing PCI were divided into reflow (n=72) and no-reflow (n=84) groups.
- A control group (n=70) of healthy volunteers was included for comparison.
- Serum CD69 and EGR1 levels were measured using flow cytometry and RT-qPCR at various time points before and after PCI.
Main Results:
- CD69 expression was significantly altered in the reflow group compared to baseline and controls.
- CD69 levels were significantly lower in the reflow group than the no-reflow group, and higher in the no-reflow group than controls.
- EGR1 levels were significantly higher in the reflow group than the no-reflow group, and lower in the no-reflow group than controls.
- Multivariate analysis identified CD69 and EGR1 as independent risk factors for no-reflow post-PCI.
Conclusions:
- CD69 and EGR1 levels are significantly associated with no-reflow phenomenon in CHD patients after PCI.
- Increased CD69 and decreased EGR1 in the early postoperative period may predict no-reflow, enabling timely intervention.
- These biomarkers could potentially improve therapeutic outcomes for CHD patients undergoing PCI.
Abstract:
Association between CD69 and EGR1 levels and coronary heart disease (CHD) patients without reflow after percutaneous coronary intervention (PCI) was investigated. Data of 156 patients undergoing PCI from September 2014 to December 2016 in People's Hospital of Hunan Province were analyzed, and they were divided into 72 cases in reflow group (group A) and 84 cases in no-reflow group (group B) according to the patient's postoperative blood flow. Another 70 volunteers undergoing normal physical examination in the same period were selected as control group (group C). The venous blood was extracted from patients before operation, at 5 min, 2 h and 6 months after operation, the serum CD69 and EGR1 levels were detected with flow cytometry and RT-qPCR methods, and association between CD69 and EGR1 levels and postoperative blood flow recovery was analyzed. CD69 expression before and 2 h after operation in group A was significant (P<0.05), and a difference in patients at 6 months after operation between group A, B and group C (P<0.05). The CD69 expression in group A was significantly lower than that in group B (P<0.05), but in group B was significantly higher than that in group C (P<0.05). The EGR1 expression in group A was significantly higher than that in group B (P<0.05), but in group B was significantly lower than that in group C (P<0.05). Multivariate logistic regression analysis revealed that CD69 (OR=6.424, P=0.025) and EGR1 (OR=3.684, P=0.013) were independent risk factors for patients without reflow after undergoing PCI. After undergoing PCI in CHD patients, if there was an increase in CD69 level and a significant decrease in EGR1 level in the early postoperative period, the patient may be suspected of having no-reflow and checked in time to improve the patient's therapeutic effect.
Related Concept Videos
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Associative Learning
Classical conditioning, also known...
High-Level and Low-Level Awareness
Leveling Effect
Levels of Organization
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
Somatosensory, Motor, and Association Cortex

